Patients with Heavily Pretreated Diffuse Large B-Cell Lymphoma (DLBCL) Who Respond to Oral Selinexor Therapy Show Prolonged Survival: Updated Phase I Results
Patients with Heavily Pretreated Diffuse Large B-Cell Lymphoma (DLBCL) Who Respond to Oral Selinexor Therapy Show Prolonged Survival: Updated Phase I Results